Neomorph is a clinical-stage biotechnology company pioneering the discovery and development of molecular glue degraders to unlock new therapeutic possibilities across serious diseases. By engineering neomorphic protein surfaces, Neomorph enables precision targeted protein degradation of disease drivers that have historically been considered undruggable. As a leader in molecular glue technology, Neomorph has created the world’s largest proprietary molecular glue target space, spanning multiple novel degrons across an expansive portfolio of E3 ubiquitin ligases. The company was founded in 2020 and is venture-backed by Deerfield Management Company.
| Website | https://neomorph.com/ |
| Employees | 90 (78 on RocketReach) |
| Founded | 2020 |
| Phone | +1 502-589-4215 |
| Technologies |
HTML
,
Google Analytics
,
reCAPTCHA
+11 more
(view full list)
|
| Industry | Biotechnology Research |
| Competitors | Amazon, Microsoft, IBM, Google, Baidu, Inc., OpenAI, Nuance Communications, Sensory, Inc., Vicarious, Real +38 more (view full list) |
Looking for a particular Neomorph, Inc. employee's phone or email?
Neomorph, Inc. Questions
Phil Chamberlain is the Co-Founder, President and CEO of Neomorph, Inc..
78 people are employed at Neomorph, Inc..
Neomorph, Inc. is based in San Diego, California.
Top Neomorph, Inc. Employees
-
Phil Chamberlain
Co-Founder, President and CEO at Neomorph, Inc.
San Diego, CA, US33 -
25+
-
Marla Bornstein
Vice President, Business Development at Neomorph, Inc.
San Diego, CA, US11 -
13
-
Sara Weymer
Vice President Clinical Operations at Neomorph, Inc.
San Diego, CA, US14 -
13
-
Rohan Beckwith
SVP Chemistry at Neomorph, Inc.
San Diego, CA, US25 -
Klaus Wagner
Chief Medical Officer at Neomorph, Inc.
United States34 -
21
Related Companies
